Globe Life Inc. (NYSE:GL – Get Free Report) Director Cheryl Alston sold 8,258 shares of the stock in a transaction on Thursday, June 25th. The stock was sold at an average price of $179.24, for a total transaction of $1,480,163.92. Following the sale, the director directly owned 16,621 shares in the company, valued at $2,979,148.04. This trade represents a 33.19% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through this link.
Globe Life Stock Performance
GL traded up $2.88 on Friday, reaching $179.28. The stock had a trading volume of 922,553 shares, compared to its average volume of 544,512. The business’s 50-day moving average price is $157.72 and its two-hundred day moving average price is $147.09. The company has a market cap of $13.92 billion, a P/E ratio of 12.40 and a beta of 0.49. Globe Life Inc. has a 12-month low of $116.73 and a 12-month high of $181.15. The company has a current ratio of 0.07, a quick ratio of 0.07 and a debt-to-equity ratio of 0.38.
Globe Life (NYSE:GL – Get Free Report) last posted its earnings results on Wednesday, April 22nd. The company reported $3.43 EPS for the quarter, missing analysts’ consensus estimates of $3.46 by ($0.03). The business had revenue of $1.56 billion for the quarter, compared to analyst estimates of $1.56 billion. Globe Life had a net margin of 19.38% and a return on equity of 20.94%. Globe Life’s revenue was up 5.3% on a year-over-year basis. During the same quarter last year, the business earned $3.07 earnings per share. Globe Life has set its FY 2026 guidance at 15.400-15.90 EPS. Sell-side analysts forecast that Globe Life Inc. will post 15.64 earnings per share for the current year.
Globe Life Dividend Announcement
Wall Street Analysts Forecast Growth
GL has been the subject of several research analyst reports. Morgan Stanley upped their price target on shares of Globe Life from $176.00 to $181.00 and gave the stock an “overweight” rating in a research report on Thursday, May 21st. Truist Financial lifted their price target on Globe Life from $180.00 to $185.00 and gave the stock a “buy” rating in a research note on Friday, April 24th. Weiss Ratings raised Globe Life from a “buy (b-)” rating to a “buy (b)” rating in a research note on Wednesday, May 13th. TD Cowen lifted their target price on shares of Globe Life from $199.00 to $215.00 and gave the stock a “buy” rating in a research note on Tuesday. Finally, Piper Sandler increased their target price on shares of Globe Life from $167.00 to $175.00 and gave the company an “overweight” rating in a research report on Tuesday, May 26th. One research analyst has rated the stock with a Strong Buy rating, eight have given a Buy rating and two have assigned a Hold rating to the stock. According to data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and an average price target of $175.89.
Read Our Latest Research Report on GL
Institutional Inflows and Outflows
Several institutional investors have recently modified their holdings of GL. CYBER HORNET ETFs LLC acquired a new stake in Globe Life during the second quarter worth about $28,000. Hilton Head Capital Partners LLC purchased a new stake in shares of Globe Life during the 4th quarter valued at approximately $30,000. MUFG Securities EMEA plc acquired a new position in Globe Life in the second quarter valued at approximately $31,000. Torren Management LLC acquired a new position in Globe Life in the fourth quarter valued at approximately $37,000. Finally, AdvisorNet Financial Inc increased its stake in Globe Life by 41.1% during the first quarter. AdvisorNet Financial Inc now owns 316 shares of the company’s stock worth $44,000 after acquiring an additional 92 shares during the last quarter. Hedge funds and other institutional investors own 81.61% of the company’s stock.
Globe Life Company Profile
Globe Life, traded on the NYSE under the symbol GL, is a U.S.-based insurance holding company that underwrites and distributes a range of life and supplemental health insurance products. Through its subsidiary brands—Globe Life, American Income Life, Liberty National Life, United American Insurance Company and Family Heritage Life—it offers term life, whole life, fixed annuities and supplemental health coverage designed to meet the needs of individuals and families across various socioeconomic segments.
The company’s product suite includes low-cost, easy-to-understand life insurance policies, accidental death and dismemberment coverage, hospital indemnity plans and specified disease insurance.
Recommended Stories
- Five stocks we like better than Globe Life
- Rocket Lab’s NASA Win Tests Key Support After Sharp Pullback
- AST SpaceMobile Just Nailed a Major Launch—So Why Is the Stock Crashing?
- Palantir’s Valuation Problem Just Met 2 New Growth Catalysts
- Xcel Energy Stock Offers Stability as Electricity Demand Builds
Receive News & Ratings for Globe Life Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Globe Life and related companies with MarketBeat.com's FREE daily email newsletter.
